Z-1008-2022 Class II Terminated

Recalled by Roche Diabetes Care, Inc. — Indianapolis, IN

FDA device recall Z-1008-2022 was initiated by Roche Diabetes Care, Inc. on Mar 9, 2022 and is designated Class II. Reason for recall: Potential for patient data mismatch when using browser "back" button to navigate between patients when using the diabetes management software. The recall status is terminated (terminated Jan 22, 2025). Affected quantity: 81 registered accounts.

Recall Details

Product Type
Devices
Report Date
May 4, 2022
Initiation Date
Mar 9, 2022
Termination Date
Jan 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
81 registered accounts

Product Description

RocheDiabetes Care Platform Software version 2.5.2 material number 08888353001. This is a web application software hosted on a server. There is no physical product.

Reason for Recall

Potential for patient data mismatch when using browser "back" button to navigate between patients when using the diabetes management software.

Distribution Pattern

US Nationwide Distribution: AK, AZ, CA, CO, DC, FL, GA, IL, IN, MN, NC, NJ, NY, PA, RI, SC, TX, WI

Code Information

Date of manufacture: 2021-11

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1008-2022
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1008-2022. Report a data issue: hello@regdatalab.com.